USS Investment Management Ltd Buys 3,580 Shares of Cardinal Health, Inc. $CAH

USS Investment Management Ltd lifted its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 8.6% during the 1st quarter, HoldingsChannel.com reports. The firm owned 45,435 shares of the company’s stock after buying an additional 3,580 shares during the period. USS Investment Management Ltd’s holdings in Cardinal Health were worth $9,600,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of CAH. Integrated Wealth Concepts LLC lifted its holdings in shares of Cardinal Health by 6.9% during the 1st quarter. Integrated Wealth Concepts LLC now owns 4,363 shares of the company’s stock worth $601,000 after acquiring an additional 280 shares during the period. Jones Financial Companies Lllp increased its stake in shares of Cardinal Health by 198.3% in the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after purchasing an additional 14,034 shares during the last quarter. Arrowstreet Capital Limited Partnership bought a new position in shares of Cardinal Health in the 2nd quarter valued at $1,935,000. Cerity Partners LLC raised its holdings in shares of Cardinal Health by 17.0% during the 2nd quarter. Cerity Partners LLC now owns 40,426 shares of the company’s stock worth $6,792,000 after buying an additional 5,880 shares in the last quarter. Finally, Nebula Research & Development LLC raised its holdings in shares of Cardinal Health by 34.4% during the 2nd quarter. Nebula Research & Development LLC now owns 10,334 shares of the company’s stock worth $1,736,000 after buying an additional 2,646 shares in the last quarter. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Trading Up 0.3%

NYSE:CAH opened at $238.31 on Thursday. The stock’s 50-day moving average is $207.54 and its 200-day moving average is $211.22. Cardinal Health, Inc. has a 1-year low of $137.75 and a 1-year high of $240.93. The stock has a market cap of $55.82 billion, a P/E ratio of 36.44, a price-to-earnings-growth ratio of 1.30 and a beta of 0.48.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.79 by $0.38. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The business had revenue of $60.94 billion during the quarter, compared to analyst estimates of $62.10 billion. During the same quarter last year, the business earned $2.35 EPS. The firm’s quarterly revenue was up 11.0% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, equities analysts forecast that Cardinal Health, Inc. will post 10.76 EPS for the current year.

Cardinal Health Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be paid a dividend of $0.5158 per share. The ex-dividend date of this dividend is Wednesday, July 1st. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.06 annualized dividend and a dividend yield of 0.9%. Cardinal Health’s payout ratio is 31.19%.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on CAH. Weiss Ratings lowered Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a research note on Tuesday, May 19th. Citigroup dropped their target price on shares of Cardinal Health from $249.00 to $245.00 and set a “buy” rating for the company in a report on Friday, May 1st. Evercore reduced their price target on shares of Cardinal Health from $260.00 to $240.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 8th. JPMorgan Chase & Co. decreased their price target on shares of Cardinal Health from $243.00 to $215.00 and set a “neutral” rating on the stock in a report on Monday, May 4th. Finally, Morgan Stanley upped their price objective on shares of Cardinal Health from $245.00 to $255.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 28th. Fourteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, Cardinal Health currently has an average rating of “Moderate Buy” and an average price target of $246.93.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.